426 related articles for article (PubMed ID: 28914501)
41. Care of transsexual persons.
Bockting W; Coleman E; De Cuypere G
N Engl J Med; 2011 Jun; 364(26):2559-60; author reply 2560. PubMed ID: 21714669
[No Abstract] [Full Text] [Related]
42. [Adolescents with gender identity disorder: reconsideration of the age limits for endocrine treatment and surgery].
Nakatsuka M
Seishin Shinkeigaku Zasshi; 2012; 114(6):647-53. PubMed ID: 22844815
[TBL] [Abstract][Full Text] [Related]
43. Short- and long-term clinical skin effects of testosterone treatment in trans men.
Wierckx K; Van de Peer F; Verhaeghe E; Dedecker D; Van Caenegem E; Toye K; Kaufman JM; T'Sjoen G
J Sex Med; 2014 Jan; 11(1):222-9. PubMed ID: 24344810
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of Sex Steroid Therapy Without Progestin or GnRH Agonist for Gonadal Suppression in Adult Transgender Patients.
Pappas II; Craig WY; Spratt LV; Spratt DI
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1290-e1300. PubMed ID: 33247919
[TBL] [Abstract][Full Text] [Related]
45. Guidelines for pubertal suspension and gender reassignment for transgender adolescents.
Hembree WC
Child Adolesc Psychiatr Clin N Am; 2011 Oct; 20(4):725-32. PubMed ID: 22051008
[TBL] [Abstract][Full Text] [Related]
46. Fertility preservation options for transgender and gender-nonconforming individuals.
Moravek MB
Curr Opin Obstet Gynecol; 2019 Jun; 31(3):170-176. PubMed ID: 30870185
[TBL] [Abstract][Full Text] [Related]
47. Heterotopic transplantation as a model to study the regulation of spermatogenesis; some histomorphological considerations about sperm decline in man.
Johnson L; Falk GU; Suggs LC; Henderson DJ; Spoede GE; Brown SW; McGowen TA; Meguerditchian H; Barnard JJ
Contracept Fertil Sex; 1997; 25(7-8):549-55. PubMed ID: 9343904
[TBL] [Abstract][Full Text] [Related]
48. Treatment of adolescents with gender dysphoria in the Netherlands.
Cohen-Kettenis PT; Steensma TD; de Vries AL
Child Adolesc Psychiatr Clin N Am; 2011 Oct; 20(4):689-700. PubMed ID: 22051006
[TBL] [Abstract][Full Text] [Related]
49. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.
Petersen PM; Skakkebaek NE; Vistisen K; Rørth M; Giwercman A
J Clin Oncol; 1999 Mar; 17(3):941-7. PubMed ID: 10071288
[TBL] [Abstract][Full Text] [Related]
50. Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects.
Moore E; Wisniewski A; Dobs A
J Clin Endocrinol Metab; 2003 Aug; 88(8):3467-73. PubMed ID: 12915619
[TBL] [Abstract][Full Text] [Related]
51. Sex reassignment: outcomes and predictors of treatment for adolescent and adult transsexuals.
Smith YL; Van Goozen SH; Kuiper AJ; Cohen-Kettenis PT
Psychol Med; 2005 Jan; 35(1):89-99. PubMed ID: 15842032
[TBL] [Abstract][Full Text] [Related]
52. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
[TBL] [Abstract][Full Text] [Related]
53. Psychological and medical care of gender nonconforming youth.
Vance SR; Ehrensaft D; Rosenthal SM
Pediatrics; 2014 Dec; 134(6):1184-92. PubMed ID: 25404716
[TBL] [Abstract][Full Text] [Related]
54. Profound Changes in Sex Hormone Levels during Cross-Sex Hormone Therapy of Transsexuals do not Alter Serum Cholesterol Acceptor Capacity.
Wultsch A; Kaufmann U; Ott J; Stojakovic T; Scharnagl H; Stangl H; Strobl WM
J Sex Med; 2015 Jun; 12(6):1436-9. PubMed ID: 25854918
[TBL] [Abstract][Full Text] [Related]
55. Serum concentrations of brain-derived neurotrophic factor in patients diagnosed with gender dysphoria undergoing sex reassignment surgery.
Schneider MA; Andreazza T; Fontanari AM; Costa AB; Silva DC; Aguiar BW; Massuda R; Pedrini M; Gama CS; Schwarz K; Kauer-Sant'Anna M; Lobato MI
Trends Psychiatry Psychother; 2017; 39(1):43-47. PubMed ID: 28403322
[TBL] [Abstract][Full Text] [Related]
56. Is hormonal therapy associated with better quality of life in transsexuals? A cross-sectional study.
Gorin-Lazard A; Baumstarck K; Boyer L; Maquigneau A; Gebleux S; Penochet JC; Pringuey D; Albarel F; Morange I; Loundou A; Berbis J; Auquier P; Lançon C; Bonierbale M
J Sex Med; 2012 Feb; 9(2):531-41. PubMed ID: 22145968
[TBL] [Abstract][Full Text] [Related]
57. Transsexual Voice Questionnaire for Male-to-female Brazilian Transsexual People.
Schwarz K; Fontanari AMV; Mueller A; Costa AB; Soll B; da Silva DC; Cielo CA; Kuhl G; Spritzer PM; Schneider MA; Dorfmann ME; Lobato MIR
J Voice; 2017 Jan; 31(1):120.e15-120.e20. PubMed ID: 27146028
[TBL] [Abstract][Full Text] [Related]
58. Testicular function in a birth cohort of young men.
Hart RJ; Doherty DA; McLachlan RI; Walls ML; Keelan JA; Dickinson JE; Skakkebaek NE; Norman RJ; Handelsman DJ
Hum Reprod; 2015 Dec; 30(12):2713-24. PubMed ID: 26409015
[TBL] [Abstract][Full Text] [Related]
59. Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist.
Ward JA; Robinson J; Furr BJ; Shalet SM; Morris ID
Cancer Res; 1990 Feb; 50(3):568-74. PubMed ID: 2137024
[TBL] [Abstract][Full Text] [Related]
60. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience.
Gooren LJ; Giltay EJ; Bunck MC
J Clin Endocrinol Metab; 2008 Jan; 93(1):19-25. PubMed ID: 17986639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
